VTYX
Ventyx Biosciences Inc.
$8.53
+$0.11(+1.31%)
59
Overall
60
Value
83
Tech
36
Quality
Market Cap
$526.26M
Volume
5.42M
52W Range
$0.78 - $9.50
Target Price
$11.50
Order:
Income Statement
| Metric | Trend | Chart | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|
| OPERATING EXPENSES | ||||||
| Operating Expenses | $-67.1M | $113.1M | $208.0M | $148.4M | ||
| Research & Development | $58.5M | $87.7M | $175.8M | $117.0M | ||
| Research Expense | $58.5M | $87.7M | $175.8M | $117.0M | ||
| Selling, General & Administrative | $8.7M | $25.4M | $32.2M | $31.4M | ||
| Selling & Marketing Expenses | $-124.0K | -- | -- | -- | ||
| General & Administrative Expenses | $8.7M | $25.4M | $32.2M | $31.4M | ||
| Salaries & Wages | $-2.7M | $16.6M | $28.6M | $22.9M | ||
| Depreciation & Amortization | $-30.0K | $123.0K | $158.0K | $266.0K | ||
| Depreciation & Amortization | $-30.0K | $123.0K | $158.0K | $266.0K | ||
| Other Operating Expenses | -- | $-860.0K | $-1.4M | $-1.0M | ||
| OPERATING INCOME | ||||||
| Operating income | $-67.1M | $-113.1M | $-208.0M | $-148.4M | ||
| EBITDA | $-83.6M | $-112.7M | $-192.0M | $-133.8M | ||
| NON-OPERATING ITEMS | ||||||
| Interest Expense (Non-Operating) | $99.0K | -- | -- | -- | ||
| Intinc | $-16.4M | $4.7M | $15.1M | $13.4M | ||
| Net Non-Operating Interest Income/Expense | $-16.5M | $4.7M | $15.1M | $13.4M | ||
| Other Income/Expense | $51.0K | $41.0K | $42.0K | $88.0K | ||
| Other Special Charges | $-51.0K | $41.0K | $-42.0K | $-88.0K | ||
| SPECIAL ITEMS | ||||||
| Restructring And Mn A Income | -- | -- | $2.2M | -- | ||
| Special Income Charges | -- | -- | $-2.2M | $-300.0K | ||
| Impairment of Capital Assets | -- | -- | $300.0K | $300.0K | ||
| PRE-TAX INCOME | ||||||
| EBIT | $-83.6M | $-113.1M | $-193.0M | $-135.1M | ||
| Pre-Tax Income | $-83.7M | $-108.4M | $-193.0M | $-135.1M | ||
| NET INCOME | ||||||
| Net Income | $-83.7M | $-108.4M | $-193.0M | $-135.1M | ||
| Net Income (Continuing Operations) | $-83.7M | $-108.4M | $-193.0M | $-135.1M | ||
| Net Income (Discontinued Operations) | $-83.7M | $-108.4M | $-193.0M | $-135.1M | ||
| Net Income (Common Stockholders) | $-85.3M | $-108.4M | $-193.0M | $-135.1M | ||
| Normalized Income | -- | -- | -- | $-133.5M | ||
| TOTALS | ||||||
| Total Expenses | $-67.1M | $113.1M | $208.0M | $148.4M | ||
| SHARE & EPS DATA | ||||||
| Average Shares Outstanding | $12.8M | $52.5M | $58.5M | $68.5M | ||
| Average Shares Outstanding (Diluted) | $12.6M | $52.5M | $58.5M | $68.5M | ||
| Shares Outstanding | $50.7M | $58.2M | $59.3M | $71.1M | ||
| Basic EPS | -- | $-2.07 | $-3.3 | $-1.97 | ||
| Basic EPS (Continuing Operations) | -- | $-2.07 | $-3.3 | $-1.97 | ||
| Diluted EPS | $-6.65 | $-2.07 | $-3.3 | $-1.97 | ||
| Diluted EPS (Continuing Operations) | -- | $-2.07 | $-3.3 | $-1.97 | ||
| OTHER METRICS | ||||||
| Accrued Preferred Stock Dividends | $1.6M | -- | -- | -- | ||
| Other Gand A | $8.7M | $25.4M | $32.2M | $31.4M | ||
| Otherunder Preferred Stock Dividend | $1.6M | -- | -- | -- | ||
| Preferred Stock Dividends | $1.6M | -- | -- | -- | ||
| Rent And Landing Fees | $8.7M | -- | -- | -- | ||
| Restruct | -- | -- | $2.2M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VTYX | $8.53 | +1.3% | 5.42M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |